AI's Canadian Frontier: Drug Discovery Breakthroughs, Copyright Battles, and Adoption Challenges

AI is simultaneously becoming Canada's most powerful research tool and its most controversial creative force, sparking breakthroughs in biotech while igniting legal battles over artistic rights.

Evidence For

• Toronto-based BenchSci just landed a two-year enterprise agreement with global immunology company argenx to deploy its AI-driven preclinical drug discovery platform, EMET. The deal marks a significant expansion into European biopharma, with scientists using the...